US court throws out first Actos verdict
This article was originally published in Scrip
Executive Summary
The Superior Court of California in Los Angeles has granted a motion by defendant Takeda and thrown out a jury verdict in the first case to come to trial claiming a link between the Japanese firm's diabetes drug Actos (pioglitazone) and bladder cancer.